Anixa Biosciences, Inc. (ANIX) is a publicly traded Healthcare sector company. As of May 21, 2026, ANIX trades at $2.81 with a market cap of $92.54M and a P/E ratio of -8.04. ANIX moved +3.18% today. Year to date, ANIX is -14.15%; over the trailing twelve months it is +4.60%. Its 52-week range spans $2.07 to $5.46. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces ANIX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Anixa Biosciences, Inc. (ANIX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ANIX moved +3.18% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $2.81 |
| Market Cap | $92.54M |
| P/E Ratio | -8.04 |
| EPS | $-0.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.46 |
| 52-Week Low | $2.07 |
| Volume | 5 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-11.03M |
| Gross Margin | 0.00% |
1 analysts cover ANIX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.00.